Literature DB >> 33672153

A Comprehensive miRNome Analysis of Macrophages Isolated from db/db Mice and Selected miRNAs Involved in Metabolic Syndrome-Associated Cardiac Remodeling.

Justyna Niderla-Bielińska1, Aneta Ścieżyńska1, Aneta Moskalik2, Ewa Jankowska-Steifer1, Krzysztof Bartkowiak3, Mateusz Bartkowiak3,4, Ewelina Kiernozek5, Anna Podgórska6, Bogdan Ciszek7, Barbara Majchrzak8, Anna Ratajska8.   

Abstract

Cardiac macrophages are known from various activities, therefore we presume that microRNAs (miRNAs) produced or released by macrophages in cardiac tissue have impact on myocardial remodeling in individuals with metabolic syndrome (MetS). We aim to assess the cardiac macrophage miRNA profile by selecting those miRNA molecules that potentially exhibit regulatory functions in MetS-related cardiac remodeling. Cardiac tissue macrophages from control and db/db mice (an animal model of MetS) were counted and sorted with flow cytometry, which yielded two populations: CD45+CD11b+CD64+Ly6Chi and CD45+CD11b+CD64+Ly6Clow. Total RNA was then isolated, and miRNA expression profiles were evaluated with Next Generation Sequencing. We successfully sequenced 1400 miRNAs in both macrophage populations: CD45+CD11b+CD64+Ly6Chi and CD45+CD11b+CD64+Ly6Clow. Among the 1400 miRNAs, about 150 showed different expression levels in control and db/db mice and between these two subpopulations. At least 15 miRNAs are possibly associated with MetS pathology in cardiac tissue due to direct or indirect regulation of the expression of miRNAs for proteins involved in angiogenesis, fibrosis, or inflammation. In this paper, for the first time we describe the miRNA transcription profile in two distinct macrophage populations in MetS-affected cardiac tissue. Although the results are preliminary, the presented data provide a foundation for further studies on intercellular cross-talk/molecular mechanism(s) involved in the regulation of MetS-related cardiac remodeling.

Entities:  

Keywords:  cardiac macrophages; metabolic syndrome; miRNA; myocardial remodeling

Mesh:

Substances:

Year:  2021        PMID: 33672153      PMCID: PMC7926522          DOI: 10.3390/ijms22042197

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  121 in total

1.  MicroRNA-29 regulates myocardial microvascular endothelial cells proliferation and migration in association with IGF1 in type 2 diabetes.

Authors:  Zhenjie Li; Runxia Jiang; Qingcai Yue; Haiying Peng
Journal:  Biochem Biophys Res Commun       Date:  2017-03-15       Impact factor: 3.575

2.  Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.

Authors:  Yan Huang; Lixue Huang; Guangfa Zhu; Zhenye Pei; Wenmei Zhang
Journal:  J Cell Physiol       Date:  2018-12-24       Impact factor: 6.384

3.  MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A.

Authors:  Carmen Urbich; David Kaluza; Timo Frömel; Andrea Knau; Katrin Bennewitz; Reinier A Boon; Angelika Bonauer; Carmen Doebele; Jes-Niels Boeckel; Eduard Hergenreider; Andreas M Zeiher; Jens Kroll; Ingrid Fleming; Stefanie Dimmeler
Journal:  Blood       Date:  2011-12-19       Impact factor: 22.113

4.  Ly6CHi Blood Monocyte/Macrophage Drive Chronic Inflammation and Impair Wound Healing in Diabetes Mellitus.

Authors:  Andrew Kimball; Matthew Schaller; Amrita Joshi; Frank M Davis; Aaron denDekker; Anna Boniakowski; Jennifer Bermick; Andrea Obi; Bethany Moore; Peter K Henke; Steve L Kunkel; Katherine A Gallagher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-01       Impact factor: 8.311

5.  MicroRNA-30 mediates anti-inflammatory effects of shear stress and KLF2 via repression of angiopoietin 2.

Authors:  Shemsi Demolli; Carmen Doebele; Anuradha Doddaballapur; Victoria Lang; Beate Fisslthaler; Emmanouil Chavakis; Manlio Vinciguerra; Sergio Sciacca; Reinhard Henschler; Markus Hecker; Soniya Savant; Hellmut G Augustin; David Kaluza; Stefanie Dimmeler; Reinier A Boon
Journal:  J Mol Cell Cardiol       Date:  2015-10-09       Impact factor: 5.000

6.  A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation.

Authors:  Guoqing Zhuang; Cong Meng; Xin Guo; Patali S Cheruku; Lei Shi; Hang Xu; Honggui Li; Gang Wang; Ashley R Evans; Stephen Safe; Chaodong Wu; Beiyan Zhou
Journal:  Circulation       Date:  2012-05-11       Impact factor: 29.690

7.  microRNA-15a-5p participates in sepsis by regulating the inflammatory response of macrophages and targeting TNIP2.

Authors:  Yufeng Lou; Zhenrong Huang
Journal:  Exp Ther Med       Date:  2020-02-25       Impact factor: 2.447

8.  MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy.

Authors:  Wei Pan; Yun Zhong; Chuanfang Cheng; Benrong Liu; Li Wang; Aiqun Li; Longgen Xiong; Shiming Liu
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

9.  MicroRNA-17, 20a regulates the proangiogenic function of tumor-associated macrophages via targeting hypoxia-inducible factor 2α.

Authors:  Zhenqun Xu; Lan Zhao; Ling-Yan Zhu; Min He; Limin Zheng; Yan Wu
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

10.  MicroRNA-31-5p Exacerbates Lipopolysaccharide-Induced Acute Lung Injury via Inactivating Cab39/AMPKα Pathway.

Authors:  Wan-Li Jiang; Kao-Chang Zhao; Wen Yuan; Fang Zhou; Heng-Ya Song; Gao-Li Liu; Jie Huang; Jin-Jing Zou; Bo Zhao; Song-Ping Xie
Journal:  Oxid Med Cell Longev       Date:  2020-10-08       Impact factor: 6.543

View more
  1 in total

Review 1.  Multiple roles of cardiac macrophages in heart homeostasis and failure.

Authors:  Aneta Moskalik; Justyna Niderla-Bielińska; Anna Ratajska
Journal:  Heart Fail Rev       Date:  2021-08-13       Impact factor: 4.654

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.